Get started
Source

Poster Session Abstracts

Source type: journal
Publisher:
Fully OA: No
DOAJ: No
OpenAlex ID: S4363607033
Evaluation of genomic changes in ductal carcinoma in situ as potential biomarkers of recurrence risk
2020 · Dorothea Lesche, Hugo Saunders, et al. · Poster Session Abstracts
Neratinib plus trastuzumab plus fulvestrant for HER2-mutant, hormone receptor-positive, metastatic breast cancer: Updated results from the phase 2 SUMMIT 'basket' trial
2020 · Hans Wildiers, Valentina Boni, et al. · Poster Session Abstracts
ER pathway activity signature as a biomarker for endocrine agent GDC-9545
2020 · Anneleen Daemen, Jill M. Spoerke, et al. · Poster Session Abstracts
Reactive stroma and trastuzumab resistance in HER2-positive early breast cancer
2020 · Amir Sonnenblick, Mali Salmon‐Divon, et al. · Poster Session Abstracts
The interplay between stromal density, epithelial mesenchymal transition and chemoresistance in breast cancer
2019 · Veenoo Agarwal, LJ Spalding, et al. · Poster Session Abstracts
Abstract P1-07-06: The relationship between Klintrup-Makinen score and cancer-specific survival in primary operable breast cancer
2018 · ES Morrow, F Gujam, et al. · Poster Session Abstracts
Risk-reducing oophorectomy and breast cancer risk across the spectrum of familial risk using a prospective family study cohort (ProF-SC)
2018 · Mary Beth Terry, Kelly‐Anne Phillips, et al. · Poster Session Abstracts
Works count: 7
Citation count:
H-index:
I10-index:
2yr mean citedness:
Year
Topic
Type